Pilot study checks if routine CMV screening in early pregnancy is worth it
NCT ID NCT05699421
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 31 times
Summary
This completed study tested a universal screening program for cytomegalovirus (CMV) infection in the first trimester of pregnancy. Over 3,300 pregnant women in Barcelona were screened to measure how common CMV infection is and how often it leads to fetal or newborn problems. The goal was to see if routine screening could help identify and manage infections early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCREENING are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ASSIR Metropolitana Nord
Badalona, Spain
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could support routine CMV screening in early pregnancy to identify infections and guide monitoring.
What could go wrong
This is a pilot study, not a treatment trial. It only measures infection rates and outcomes, so it may not change practice directly.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.